Ungurianu, A., Zanfirescu, A., & Margin, D
Patients are typically started on a lower dose of tirzepatide, gradually increasing to the maximum tolerated dose under medical supervision
Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat
These signals help regulate various functions, from metabolism to healing
This common condition can result from a variety of factors, including chronic constipation, pregnancy, and straining during bowel movements
For tirzepatide at the highest dose, the SURMOUNT-1 trial showed an average of 22.5% weight loss at 72 weeks, which represents one of the most significant weight loss results ever achieved with any medication